Website
Ratings & Metrics
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| Population Council | Audited Financial Statements | 13-1687001 |
| Population Council | IRS Form 990 | 13-1687001 |
|
Entity: Population Council Document Type: Audited Financial Statements Tax ID: 13-1687001 |
|
Entity: Population Council Document Type: IRS Form 990 Tax ID: 13-1687001 |
Governance & Transparency
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Brid T. Devlin | Chief Scientific Officer, CBR | $486,986 |
| 2 | James E. Sailer | Vice President / Executive Director, CBR | $444,294 |
| 3 | Antony Dutson | Vice President, CF&A / CFO | $437,734 |
|
1 Name: Brid T. Devlin Title: Chief Scientific Officer, CBR Compensation: $486,986 |
|
2 Name: James E. Sailer Title: Vice President / Executive Director, CBR Compensation: $444,294 |
|
3 Name: Antony Dutson Title: Vice President, CF&A / CFO Compensation: $437,734 |
Analysts' Notes
CharityWatch's rating of The Population Council (the Council) also includes the financial activities of the "locally registered affiliates" included in the Council's audited consolidated financial statements for the year ended December 31, 2024. All intercompany accounts and transactions are eliminated in consolidation. Per Audit Note 1 of the Council's audited consolidated financial statements: "Included in these offices are three locally registered organizations in India, Kenya, and Pakistan which do not have income tax filing obligations and a for-profit affiliate in India that is subject to Indian taxation...All four affiliates have elected to be disregarded for U.S. income tax purposes..." |
According to The Population Council (the Council) consolidated audit of December 31, 2024 (Note 2, Summary of Significant Accounting Policies, Concentration of Support): "During 2024, approximately $4.2 million of the Council’s grants were funded by the National Institutes of Health (NIH)... ...The three largest funding sources, one U.S. government agency, one foreign government agency, and one
private foundation, constitute 22% of the revenue in 2024..." |
According to The Population Council (the Council) consolidated audit of December 31, 2024 (Note 17, Subsequent Events): "...Based on the agreement between the Council and Mayne Pharma LLC, royalty revenue amounting to $13 million related to the transfer of functional intellectual property was recognized in the financial statements for the year ending December 31, 2023. The corresponding cash receipt for this revenue was received in March 2025. In January 2025, the U.S. government paused almost all foreign aid programs and initiated a 90-day review period to assess alignment of programs with current administration policy. Following this review, seven USAID grant agreements were terminated that will reduce revenues by approximately $2.8M in 2025. NIH and Department of State grants have not been impacted so far. Given the loss in revenues, management has implemented cost reduction measures along with programmatic shifts to mitigate this exposure. Given these measures and the Council’s available cash and investments...management believes that the Council has sufficient liquidity to meet its liabilities for at least one year from the date of the issuance of these financial statements." |
According to The Population Council's (the Council) tax filing for the fiscal year ended December 31, 2024, the Organization reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III): Regarding severance payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 4a): "During the year Julia Bunting Thring and Harriet Birungi received severance payments of $318,047 and $224,658[,] respectively..." [The above individuals' total reported compensation during 2024 was $318,047 and $348,544, respectively (IRS Form 990, Schedule J, Part II)]. Additionally, Antony Dutson, Vice President, CF&A/CFO, received $25,000 of "bonus & incentive compensation" along with total reported compensation of $437,734 during 2024 (IRS Form 990, Schedule J, Part II)]. |